REPRISE II data demonstrate sustained safety and performance outcomes at one year
New data from the Boston Scientific clinical trial program of the Lotus™ Valve System continue to demonstrate strong performance as a less invasive treatment for patients with severe aortic stenosis who are considered high risk for surgical valve replacement. September 15, 2014